<DOC>
	<DOCNO>NCT00002364</DOCNO>
	<brief_summary>To obtain preliminary evidence antiretroviral activity 1592U89 administer combination specific NRTI agent NRTI experience patient assess safety tolerance multiple oral dos 1592U89 administer combination specific market NRTIs .</brief_summary>
	<brief_title>A Study 1592U89 Combined With Other Anti-HIV Drugs Patients Who Have Taken Anti-HIV Drugs</brief_title>
	<detailed_description>Patients receive oral dos 1592U89 combination protocol specific current antiretroviral therapy . The treatment group assign base subject 's previous NRTI experience . The study medication self administer evaluation perform outpatient basis . Patients see day 0 week 2 , 4 , 12 , 16 , 20 24 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Patients must : CD4+ cell count &gt; = 100 /mm3 . Plasma HIV RNA &gt; = 30,000 copies/ml . Study participant may recruit clinical category , provide meet exclusion criterion . Parent legal guardian sign write , informed consent patient age 18 . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Patients active ongoing AIDSdefining opportunistic infection disease . NOTE : For study , CD4+ cell count &lt; = 200 cells/mm3 absence AIDS defining indicator condition consider AIDS define event . Malabsorption syndrome gastrointestinal dysfunction might interfere drug absorption . Patients life threaten infection serious medical condition whose participation may compromise patient safety . Concurrent Medication : Excluded : Treatment cytotoxic chemotherapeutic agent within 24 week study . Patients receive investigational drug . Foscarnet therapy therapy agent document activity HIV vitro . Treatment immunomodulators . Patients methadone . Concurrent Treatment : Excluded : Treatment radiation therapy within 24 week study . NOTE : Localized radiation therapy may permit follow consultation sponsor . Patients follow prior condition exclude : Subjects history lymphoma . Subjects history clinically apparent pancreatitis hepatitis within last 6 month . Prior Medication : Excluded : Treatment antiretroviral therapy NRTIs ( alone combination ) define treatment group . Treatment nonnucleoside RT inhibitor protease inhibitor . Treatment cytotoxic chemotherapeutic agent within 1 month prior study entry . Investigational HIV vaccine within past 3 month . Immunomodulating agent systematic corticosteroid , interleukin , thalidomide , anticytokine agent , antioxidant interferon within 1 month study entry . Prior Treatment : Excluded : Treatment radiation therapy within 1 month entry . Risk Behavior : Excluded : Patients current alcohol illicit drug use , opinion principal investigator , may interfere patient 's ability comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1997</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>